Trusted Home Care Services in Ghaziabad– Round-the-Clock Nursing & Assistance

AtHomeCare Premium Off-Canvas Menu
Home Nursing, Elderly Care & Patient Care Services in Ghaziabad | AtHomeCare

Castleman Disease Home Recovery | Patient Case Study

Castleman Disease Home Recovery | Fictional Patient Case Study

Educational Case Study

Home Recovery for Castleman Disease

A detailed clinical documentation of how structured home healthcare supported the post-discharge recovery of a 62-year-old patient diagnosed with Idiopathic Multicentric Castleman Disease in Ghaziabad, Uttar Pradesh.

Patient Age
62 Years
Gender
Female
Location
Ghaziabad, UP
Primary Condition
iMCD (Castleman Disease)
Duration of Home Care
12 Weeks
Final Outcome
Improved Mobility, No Readmission
Disclaimer

This case study is entirely fictional and created solely for educational purposes. It does not represent a real patient. Any resemblance to actual individuals is purely coincidental. The information provided is intended for education only and should not be used as a substitute for professional medical advice, diagnosis, or treatment.

Patient Background

Mrs. Farzana Naqvi is a 62-year-old retired university librarian who spent over three decades managing academic library systems before retirement. She lives in Ghaziabad, Uttar Pradesh, with her husband, Mohammad Arif Naqvi, who is 66 years old. Her daughter, Sana Naqvi, is a clinical psychologist based in Noida and serves as the secondary caregiver.

Before her illness, Mrs. Naqvi led an active daily life. She managed household responsibilities independently, attended community gatherings, read extensively, and maintained a structured daily routine. Her baseline functional status was fully independent in all activities of daily living, including bathing, dressing, cooking, and community mobility.

Medical History

Mrs. Naqvi had four pre-existing conditions that required ongoing management before her Castleman Disease diagnosis:

  • Essential Hypertension for 9 years, managed with prescribed antihypertensive medication
  • Vitamin B12 Deficiency, requiring periodic supplementation
  • Mild Osteoarthritis of both knees, causing occasional discomfort during prolonged walking or stair climbing
  • Prediabetes, monitored through dietary modification and periodic blood sugar assessment

These comorbidities meant that any new illness would need to be managed within the context of her existing medication regimen and functional limitations. The presence of prediabetes and vitamin B12 deficiency also meant her nutritional status and immune function required careful attention during recovery.

Family Situation and Caregiver Context

Her primary caregiver is her husband, who is himself a senior citizen at 66. While he is physically active and mentally sharp, managing a complex post-discharge recovery plan for a rare lymphoproliferative disorder would be beyond what any untrained family caregiver can safely handle alone. This is a reality that many families in Ghaziabad face when elderly patients return home after major hospitalization.

Her daughter in Noida, despite being a healthcare professional, lives separately and cannot provide daily hands-on care. The geographic distance between Noida and Ghaziabad, while manageable for periodic visits, creates a gap in daily supervision that professional home healthcare is designed to fill. Many families in the Delhi NCR region navigate this exact challenge: specialized treatment happens in one city, but recovery happens at home in another.

Clinical Note: Why Family Care Alone Was Insufficient

Castleman Disease is a rare disorder. Even a family member who is a clinical psychologist would not have the nursing skills needed for vital signs monitoring, infection surveillance, or medication administration for a hematological condition. The husband, at 66, was also at risk of caregiver burnout if left to manage recovery alone. Family care, while essential for emotional support, cannot replace clinical nursing skills in post-discharge recovery from a rare immune-mediated condition.

Clinical Diagnosis

Mrs. Naqvi developed symptoms gradually over approximately six months before receiving a definitive diagnosis. The initial presentation was nonspecific, which is typical for Idiopathic Multicentric Castleman Disease (iMCD) and is one of the reasons this condition is frequently misdiagnosed in its early stages.

Presenting Symptoms

  • Persistent fatigue that progressively worsened over weeks
  • Enlarged lymph nodes in the neck and underarms, palpable on self-examination
  • Unexplained weight loss over the preceding months
  • Recurrent low-grade fever that did not resolve with antibiotics
  • Excessive night sweats requiring change of clothing
  • Mild breathlessness that developed later in the course
  • Abdominal fullness due to enlarged abdominal lymph nodes

Initially, she was treated for recurrent infections with antibiotic courses. However, her symptoms continued to progress despite treatment. This pattern of treatment failure is an important clinical signal. When a patient with recurrent fever, lymphadenopathy, and weight loss does not respond to standard infection treatment, the clinical suspicion must shift toward lymphoproliferative or autoimmune processes.

Diagnostic Workup

She was eventually admitted to a tertiary hematology and oncology center where a comprehensive diagnostic evaluation was performed. The following investigations were conducted:

InvestigationPurpose
Complete Blood InvestigationsAssess hemoglobin, white blood cell count, platelet levels, and overall blood profile
Contrast-Enhanced CT ScanVisualize lymph node enlargement across body regions
PET-CT ImagingAssess metabolic activity of lymph nodes and identify areas of active disease
Excisional Lymph Node BiopsyObtain tissue for definitive histopathological diagnosis
Bone Marrow ExaminationEvaluate bone marrow involvement
ImmunohistochemistryCharacterize the specific cell types and markers involved
Serum Inflammatory MarkersQuantify the degree of systemic inflammation (CRP, ESR, IL-6)
HIV ScreeningExclude HIV-associated Castleman Disease
Autoimmune ProfileExclude autoimmune conditions that can mimic iMCD

Final Diagnosis

After multidisciplinary evaluation involving hematologists, pathologists, and radiologists, Mrs. Naqvi was diagnosed with Idiopathic Multicentric Castleman Disease (iMCD).

Understanding Castleman Disease

Castleman Disease is a rare lymphoproliferative disorder that affects the immune system. It causes abnormal enlargement of lymph nodes and excessive immune system activation. The “idiopathic multicentric” form means that the cause is unknown, multiple lymph node groups are involved across the body, and the condition behaves systemically rather than staying localized. It is not classified as a traditional cancer, but it requires specialist hematology treatment and long-term follow-up.

The distinction between unicentric and multicentric Castleman Disease is clinically important. Unicentric disease affects a single lymph node region and is often treated with surgical removal. Multicentric disease, as in this case, involves multiple node groups and requires systemic therapy. The “idiopathic” classification further indicates that no underlying cause such as HIV or HHV-8 infection was identified, making long-term monitoring even more critical since the disease behavior is less predictable.

Hospital Treatment

Mrs. Naqvi was admitted for a total of 16 days. During this period, the treating team addressed the acute inflammatory state, initiated disease-specific therapy, stabilized her comorbid conditions, and prepared the family for the transition to home-based care.

Treatment Received During Hospitalization

InterventionClinical Rationale
Monoclonal Antibody TherapyTargeted immunotherapy to reduce the excessive immune activation driving the disease
Corticosteroid TherapySuppress systemic inflammation and reduce inflammatory cytokine production
Supportive TreatmentIV fluids, symptomatic management, and nutritional support during acute phase
Nutritional RehabilitationAddress weight loss and build nutritional reserves for recovery
PhysiotherapyPrevent deconditioning during bed rest and begin early mobilization
Comprehensive Caregiver EducationPrepare the family for home-based monitoring and care

Discharge Status

By the time of discharge, the following clinical improvements had been documented:

  • Lymph node swelling had reduced significantly
  • Inflammatory markers had improved from admission levels
  • No active fever was present
  • General condition was stable for home-based continuation of care

However, stability at discharge does not mean full recovery. The patient was being sent home with a complex medication regimen, ongoing fatigue, reduced physical endurance, and the need for continuous monitoring. This is a phase that many families underestimate. The period immediately after discharge is often the most vulnerable for elderly patients with rare conditions.

Why Home Healthcare Was Needed

The decision to arrange professional home healthcare was not optional. It was clinically necessary for several specific reasons related to Mrs. Naqvi’s condition, her comorbidities, and her home situation.

1. Rare Disease Requires Specialized Monitoring

Idiopathic Multicentric Castleman Disease is rare enough that most general practitioners have limited experience managing it. The home nursing team needed to understand the specific parameters to monitor: not just routine vitals, but inflammatory symptoms, lymph node palpation, and subtle signs of disease flare that a non-specialist might miss. Recognizing early warning signs in a rare disease requires trained observation.

2. Immunosuppression Increases Infection Risk

The monoclonal antibody therapy and corticosteroids used to treat iMCD work by suppressing parts of the immune system. While this controls the disease, it also leaves the patient vulnerable to opportunistic infections. Daily home nursing was needed to perform infection surveillance: monitoring temperature, checking for respiratory symptoms, observing wound sites, and ensuring hygiene standards were maintained. Even common infections like cold or flu can become serious in an immunosuppressed patient.

3. Multiple Comorbidities Required Concurrent Management

Mrs. Naqvi’s hypertension needed ongoing blood pressure monitoring. Her prediabetes required dietary management and periodic blood sugar checks. Her vitamin B12 deficiency needed supplementation tracking. Her knee osteoarthritis affected her mobility rehabilitation. Managing all of these simultaneously, alongside the Castleman Disease follow-up, requires the kind of systematic approach that professional home nursing for patients with multiple chronic conditions is designed to provide.

4. Primary Caregiver Was Also a Senior Citizen

Her 66-year-old husband could provide emotional support and companionship, but expecting him to manage medication timing, vital signs documentation, infection monitoring, physiotherapy scheduling, and emergency recognition was neither safe nor fair. In Ghaziabad, many families rely on untrained domestic help to fill this gap, which often leads to preventable complications. A trained patient care attendant provided the right level of support.

5. Emergency Access Considerations in Ghaziabad

Ghaziabad’s traffic patterns, particularly along NH-24 and areas around major intersections, can delay ambulance response during peak hours. For a patient with a rare immune-mediated condition, any sudden deterioration (such as a fever spike or breathing difficulty) requires immediate recognition and response. Having a trained professional at home means the first critical minutes of an emergency are not lost to traffic. The home team was educated on emergency warning signs and response protocols specific to elderly patients.

Clinical Reasoning: Why Not Just OPD Follow-Up?

Some families assume that monthly hospital visits are sufficient after discharge. For a common condition with a straightforward recovery, this might be adequate. But iMCD requires monitoring of inflammatory markers, lymph node status, and immune function on an ongoing basis. Waiting a month between checks means a relapse could progress significantly before detection. Home healthcare bridges this gap by providing daily clinical observation with monthly doctor oversight.

Home Care Plan by AtHomeCare

The home care plan was developed based on the discharge summary, treating hematologist’s recommendations, and a detailed initial assessment of the patient’s home environment, functional status, and family capacity. Each component of the plan addressed a specific clinical need.

Home Nursing

A trained home nurse was assigned to provide daily clinical monitoring and medical support. The home nursing service was the clinical backbone of the recovery plan.

Responsibilities included:

  • Vital signs monitoring: Blood pressure, heart rate, respiratory rate, temperature, and oxygen saturation recorded every morning and evening. Given her hypertension history, blood pressure trends were particularly important to track.
  • Medication administration: Ensuring all prescribed medications (hematological, antihypertensive, B12 supplementation) were taken at correct times and doses. Medication management in elderly patients is critical because errors are common when multiple drugs are prescribed.
  • Inflammatory symptom monitoring: Checking for new or enlarging lymph nodes, recording any fever episodes, and documenting fatigue levels. These are the key indicators of disease activity in iMCD.
  • Nutritional assessment: Monitoring food intake, documenting appetite changes, and coordinating with the family on meal preparation.
  • Weight monitoring: Daily weight checks to detect any unplanned weight loss, which could signal disease recurrence or nutritional decline.
  • Infection surveillance: Monitoring for signs of respiratory infection, urinary tract infection, skin infections, or any other source of fever. Given the immunosuppressed state, even minor infections needed prompt attention.
  • Blood pressure monitoring: Dedicated tracking for her essential hypertension, ensuring it remained within the target range while accounting for medication interactions.
  • Coordination with hematologist: Regular communication with the treating specialist regarding clinical findings, medication tolerance, and any concerning trends.

Patient Attendant

A trained patient care attendant was assigned to provide day-to-day functional support. This role is distinct from nursing: the attendant handles activities of daily living while the nurse handles clinical tasks.

Responsibilities included:

  • Walking supervision: Accompanying her during walks to prevent falls, especially given her knee osteoarthritis and post-illness weakness
  • Meal assistance: Helping with meal setup, ensuring she ate on schedule, and encouraging adequate fluid intake
  • Medication reminders: Reinforcing medication timing between nursing visits
  • Daily activity support: Assisting with household tasks that she could not yet manage independently, such as laundry and cleaning
  • Emotional reassurance: Providing consistent companionship and reducing the anxiety she felt about disease recurrence
  • Hydration encouragement: Ensuring she consumed adequate fluids throughout the day, which is important for immune function and overall recovery
  • Appointment coordination: Helping schedule and prepare for doctor visits and physiotherapy sessions
  • Fatigue management: Recognizing when she needed rest and structuring daily activities to balance activity and recovery
Clinical Note: The Difference Between a Nurse and an Attendant

Families in Ghaziabad often confuse these two roles. A home nurse is qualified to perform clinical tasks: vital signs, medication administration, wound care, and clinical assessment. A patient attendant is trained for daily living support: mobility assistance, hygiene help, feeding support, and companionship. In this case, both were needed because Mrs. Naqvi had clinical monitoring requirements (handled by the nurse) and functional support needs (handled by the attendant). Understanding this distinction prevents gaps in care.

Physiotherapy at Home

A qualified physiotherapist visited the home to provide a structured rehabilitation program. Physiotherapy at home was essential because traveling to a clinic for sessions would have added physical strain during early recovery.

Treatment goals included:

  • Improve endurance: Gradually increasing the duration and intensity of physical activity to rebuild stamina lost during illness and hospitalization
  • Progressive walking program: Starting from her baseline of 250 meters and systematically increasing distance over weeks
  • Whole-body strengthening: Gentle resistance exercises to rebuild muscle strength without overexertion
  • Balance training: Reducing fall risk, which was especially important given her knee osteoarthritis and post-illness deconditioning
  • Functional mobility exercises: Training for real-world tasks like getting up from a chair, climbing stairs, and carrying light objects
  • Joint flexibility exercises: Maintaining range of motion in knees and other joints affected by prolonged inactivity
  • Energy conservation training: Teaching her how to pace activities throughout the day to avoid fatigue crashes
  • Home exercise education: Providing a safe exercise routine she could follow independently between physiotherapy sessions

The physiotherapy approach was deliberately conservative. After a serious illness like iMCD, pushing too hard too fast can be counterproductive. The rehabilitation program was individually tailored to her daily energy levels, not a fixed protocol.

Doctor Home Visit

A monthly doctor home visit was scheduled for hematology review. This served several purposes:

  • Assess overall treatment response through physical examination and symptom review
  • Review inflammatory marker trends documented by the home nurse
  • Evaluate medication effectiveness and adjust dosages if needed
  • Perform lymph node palpation to detect any recurrence of enlargement
  • Review comorbidity management (blood pressure, blood sugar, B12 levels)
  • Provide early detection of relapse, which is critical in iMCD

The home visit setting also allowed the doctor to observe the patient in her actual living environment, assess the home care setup, and identify any environmental factors affecting recovery. This is an advantage that clinic visits cannot provide.

Medical Equipment at Home

The following equipment was arranged through medical equipment rental to support the home care plan:

Blood Pressure Monitor
Pulse Oximeter
Digital Thermometer
Digital Weighing Scale
Medication Organizer
Resistance Exercise Bands

Each piece of equipment served a specific clinical purpose. The blood pressure monitor was essential for her hypertension management. The pulse oximeter and thermometer supported infection surveillance. The weighing scale tracked nutritional status. The medication organizer prevented dosing errors. The resistance bands supported her physiotherapy program. Having these tools at home meant that monitoring happened daily rather than only during clinic visits.

Daily Care Schedule

The day was structured to balance clinical monitoring, physical activity, nutrition, and rest. Here is how a typical day was organized:

Morning

  • Vital signs monitoring (BP, HR, RR, temperature, SpO2)
  • Morning medications administered by nurse
  • Protein-rich breakfast with hydration assessment
  • Walking exercises as per physiotherapy plan
  • Hydration tracking and encouragement

Afternoon

  • Balanced lunch with nutritional documentation
  • Physiotherapy session (strength and mobility)
  • Rest period to prevent overexertion
  • Gentle stretching exercises
  • Nutritional supplementation if prescribed

Evening

  • Outdoor walking (progressive distance)
  • Balance and coordination exercises
  • Medication review and compliance check
  • Family interaction and social engagement
  • Relaxation techniques for sleep preparation

Night

  • Light, easily digestible dinner
  • Night medications administered
  • Sleep hygiene measures implemented
  • Adequate rest with overnight monitoring plan

Risks Being Monitored

Throughout the 12-week home care period, the clinical team actively monitored for the following risks. Each risk was assessed daily or weekly depending on its urgency.

Disease Relapse
New lymph node enlargement, rising inflammatory markers, return of fever or night sweats
Opportunistic Infections
Respiratory, urinary, or skin infections due to immunosuppressive therapy
Medication Side Effects
Corticosteroid-related effects, drug interactions with antihypertensives
Falls
Increased risk due to knee osteoarthritis, muscle weakness, and fatigue
Nutritional Deficiency
Inadequate protein intake, worsening B12 deficiency, or prediabetes mismanagement
Declining Physical Endurance
Failure to regain strength, reduced mobility, or increasing dependence
Hospital Readmission
Preventable through early detection and intervention at home
Why Relapse Monitoring Was the Highest Priority

In iMCD, relapse can occur even after successful initial treatment. The disease is unpredictable because its underlying cause is unknown (“idiopathic”). This means that the absence of symptoms does not guarantee continued remission. The home nurse was specifically trained to look for subtle signs: a slight temperature elevation that might not bother the patient, a small lymph node that the family might not notice, or a gradual increase in fatigue that could be dismissed as normal aging. Normal-looking vitals can sometimes mask early deterioration, which is why trained observation matters.

Home Care Goals

The care plan had both short-term and long-term objectives. Each goal was measurable and tracked through the documentation system.

Short-Term Goals (Weeks 1 to 4)

  • Improve muscle strength through structured physiotherapy
  • Restore physical endurance to pre-hospitalization levels
  • Maintain or improve nutritional status through dietary support
  • Prevent any infection through hygiene monitoring and surveillance
  • Increase daily activity tolerance progressively without triggering fatigue
  • Establish stable medication compliance across all prescriptions

Long-Term Goals (Weeks 5 to 12 and Beyond)

  • Maintain disease remission through consistent monitoring
  • Improve overall quality of life and emotional well-being
  • Preserve functional independence in all activities of daily living
  • Prevent complications including infections, falls, and nutritional decline
  • Reduce caregiver burden on the husband and daughter
  • Avoid hospital readmissions through early intervention

Family Education

Education was not a one-time session at discharge. It was an ongoing process throughout the 12 weeks. The healthcare team systematically educated the family on the following areas:

Understanding the Disease

The family was taught that Idiopathic Multicentric Castleman Disease is a rare immune-mediated lymphoproliferative disorder. “Idiopathic” means the cause is not yet understood. “Multicentric” means it involves multiple lymph node groups. This is not cancer in the traditional sense, but it requires long-term specialist follow-up because the disease can relapse. The family needed to understand that remission does not equal cure, and that vigilance is a permanent part of life after iMCD.

Medication Adherence

The importance of taking every prescribed medication on schedule was emphasized repeatedly. Skipping doses or stopping medication because the patient “feels fine” is a common and dangerous pattern. Medication safety in elderly home care requires understanding potential drug interactions, especially between the hematological medications and her antihypertensive drugs.

Symptom Monitoring at Home

The family was trained to observe and report:

  • Body temperature changes, even low-grade elevations
  • Appetite changes or unexplained weight loss
  • Any new or enlarging lumps (lymph nodes) in the neck, armpits, or groin
  • Persistent or worsening fatigue beyond normal tiredness

Nutrition and Hydration

A balanced, protein-rich diet with adequate hydration was prescribed to support immune recovery. Nutrition and hydration in elderly care directly affects immune function, wound healing, and energy levels. The family was guided on meal planning that accounted for her prediabetes (limiting refined sugars) while ensuring adequate protein for muscle recovery.

Exercise Guidance

The family was encouraged to support regular low-impact exercise while explicitly avoiding overexertion. The physiotherapist explained the concept of energy conservation: spreading activities throughout the day rather than clustering them, resting before feeling exhausted rather than after, and gradually increasing activity rather than attempting too much at once.

Infection Prevention

Good hand hygiene, avoiding contact with people who have contagious illnesses, and prompt reporting of any infection signs were reinforced repeatedly. During winter months in the Delhi NCR region, respiratory infections are common, and an immunosuppressed patient needs extra protection. The family was advised to limit visitors during peak cold and flu season and to ensure anyone entering the home practiced hand hygiene.

Warning Signs Requiring Immediate Attention

Red Flag Symptoms: When to Seek Urgent Medical Care

The family was instructed to seek immediate medical attention if any of the following occurred:

  • Persistent fever that does not resolve within 24 hours
  • Rapidly enlarging lymph nodes
  • Severe fatigue that prevents getting out of bed
  • Difficulty breathing or chest discomfort
  • Unexplained bleeding from any site
  • Sudden, significant weight loss over days rather than weeks

The reason stable patients can suddenly deteriorate is that compensatory mechanisms can mask underlying decline until a threshold is crossed. Early reporting of these symptoms allows intervention before a crisis develops.

Emotional Support

Mrs. Naqvi had mild anxiety about disease recurrence. This is entirely expected after a diagnosis of a rare, unpredictable condition. The family was guided on providing emotional support without dismissing her concerns. Her daughter, being a clinical psychologist, was particularly helpful in this area, but the home care team also incorporated emotional reassurance into daily interactions. Mental health in senior years directly affects physical recovery, sleep quality, and medication adherence.

Recovery Timeline

The following timeline documents the clinical progress observed over 12 weeks of structured home healthcare. Each stage reflects actual observations recorded by the home nursing and physiotherapy team.

Day 1: Home Care Begins

Initial assessment completed. Mrs. Naqvi appeared frail but stable. Vital signs were within acceptable ranges. She could walk independently but tired after approximately 250 meters. Appetite was poor. She expressed anxiety about being away from the hospital environment. The home nurse established baseline measurements for all parameters. The attendant settled into the daily routine. The husband reported feeling relieved that professional help had arrived.

Nursing intervention: Complete vital signs baseline, medication reconciliation to verify all discharge prescriptions were available at home, home safety assessment for fall risks.

Doctor review: Initial home visit to confirm the care plan was appropriate and to establish the monitoring schedule.

Day 3: Establishing Routine

The daily schedule began to take shape. Mrs. Naqvi was more cooperative with medication taking when the nurse administered them rather than relying on self-administration. Morning walking was initiated at a gentle pace within the home. Sleep remained disturbed, which the nurse documented and reported to the doctor. The attendant noted that she ate better when meals were served at consistent times rather than when she felt like eating.

Clinical observation: No fever, no new lymph node enlargement, blood pressure stable at 130/82 mmHg.

Family observation: The husband said he slept better knowing someone competent was present overnight.

Week 1: Early Adaptation

By the end of the first week, a routine was established. Mrs. Naqvi began to trust the home care team. Physiotherapy sessions started with gentle range-of-motion exercises and short walks inside the home. She could walk approximately 300 meters with a brief rest. Appetite showed slight improvement. The anxiety was still present but less intense. No clinical concerns were identified.

Nursing intervention: Continued daily monitoring, hydration tracking showed she was drinking approximately 1.5 liters daily, which was below the target of 2 liters. The nurse increased hydration encouragement strategies.

Physiotherapy note: Knee discomfort was noted during squatting movements. The physiotherapist modified the exercise plan to avoid deep knee bends.

Week 2: Gradual Improvement

Walking distance increased to approximately 350 meters. Appetite improved noticeably. She began asking for specific foods, which the family and nurse took as a positive sign. Sleep quality started to improve with the relaxation techniques introduced in the evening routine. She was able to bathe and dress independently without any assistance. No fever episodes occurred. Blood pressure remained well controlled.

Doctor review: Second home visit. The doctor noted satisfactory early progress. Inflammatory markers were stable. Medications were continued as prescribed. The doctor counseled the family that recovery would be gradual and that patience was important.

Clinical progress: Weight was stable. No lymph node changes. Hydration improved to approximately 1.8 liters daily.

Week 4: Measurable Gains

By the end of the first month, walking distance had increased to approximately 450 meters. Mrs. Naqvi reported feeling “more like herself.” She began reading again, which she had stopped during her illness. She could manage most household tasks independently, though she still needed help with heavy lifting and deep cleaning. Fatigue was still present in the afternoons but was less severe than at discharge. Her daughter visited from Noida and noted visible improvement compared to the discharge day.

Nursing intervention: The nurse began reducing visit frequency slightly as the patient became more stable, while maintaining daily vital signs checks.

Physiotherapy note: Resistance band exercises were introduced. Balance training was intensified. The physiotherapist documented improved knee function compared to the initial assessment.

Family observation: The husband reported that his wife was more talkative and engaged, which he saw as a sign of emotional recovery.

Month 2: Building Momentum

The second month saw continued progress. Walking distance reached approximately 550 meters. Mrs. Naqvi began going for short walks outside the home with the attendant. Her appetite was now described as “normal” by the family. She started attending a small community gathering, which marked a significant psychological milestone. Sleep had normalized. The mild anxiety about recurrence was still present but she was able to manage it with the coping strategies discussed with her daughter.

Doctor review: Monthly review showed continued stable inflammatory markers. No evidence of disease recurrence. The doctor expressed satisfaction with the recovery trajectory. Blood pressure was well controlled. Blood sugar levels remained in the prediabetes range with no progression.

Clinical progress: No infections occurred during this period despite seasonal respiratory illness in the community. The infection prevention measures appeared to be working.

Month 3 (Week 12): Consolidated Recovery

At the 12-week mark, the improvement was significant and measurable. Walking distance had increased from 250 meters at discharge to approximately 660 meters. Mrs. Naqvi was performing most household activities independently. She could walk to nearby locations for errands. Her appetite had fully returned. Fatigue was minimal and manageable. No fever, no new lymph node enlargement, and no infections had occurred throughout the entire 12-week period.

Doctor review: The doctor documented the clinical improvement and recommended continuation of the home care plan with reduced intensity. Long-term hematology follow-up was scheduled. The doctor noted that the patient had achieved the short-term goals and was progressing well toward long-term goals.

Family feedback: Both the husband and daughter expressed satisfaction with the home care experience. They specifically noted that having a trained team at home gave them confidence and reduced their anxiety significantly.

Clinical Evidence

The following tables document the clinical parameters recorded during the home care period. All values are derived from the documented assessments.

Vital Signs at Discharge (Baseline)

ParameterValueAssessment
Blood Pressure128/80 mmHgWithin target range for hypertensive patient
Heart Rate79 bpmNormal sinus rhythm
Respiratory Rate18/minNormal
Temperature98.4°FAfebrile
Oxygen Saturation98% on Room AirNormal

Hematology Assessment at Discharge

ParameterFinding
Lymph Node EnlargementMarked reduction from admission
Inflammatory MarkersStable and improved from admission
Active FeverNone
AppetiteImproving
Hemoglobin LevelsStable
HepatosplenomegalyNo progression
Muscle StrengthMild generalized weakness
Hydration StatusNormal
Active InfectionNone
Medication ComplianceGood

Functional Assessment at Discharge

CategoryDetails
MobilityWalked independently, approximately 250 meters, mild fatigue after prolonged walking
Bed MobilityIndependent
TransfersIndependent
Required Assistance WithCarrying heavy groceries, long-distance walking, heavy cleaning, gardening, community travel, laundry, climbing multiple flights, rearranging heavy furniture
Independent InBathing, dressing, toileting, eating, communication, medication management, personal grooming, decision-making

12-Week Clinical Outcome Summary

Outcome MeasureAt DischargeAt 12 WeeksChange
Walking Distance~250 meters~660 metersSignificant improvement
AppetitePoorNormalFull recovery
Fatigue LevelOccasional, significantMinimal, manageableMarked reduction
Muscle StrengthMild generalized weaknessSteadily improvedProgressive improvement
Fever EpisodesNone at dischargeNone during 12 weeksMaintained
Lymph Node StatusMarkedly reducedNo new enlargementMaintained remission
Nutritional StatusSuboptimalImprovedPositive trend
Hospital ReadmissionsN/AZeroGoal achieved
Independence LevelPartial (needed help with multiple tasks)Mostly independent in household and community activitiesSignificant functional gain

Recovery Outcome at 12 Weeks

Mobility

Walking distance improved from approximately 250 meters to approximately 660 meters over 12 weeks. This represents a 164% improvement in walking endurance. Mrs. Naqvi could now walk independently within her community, visit nearby shops, and move around her home without fatigue limiting her activities. She no longer needed supervision for routine walking.

Energy and Fatigue

Fatigue reduced significantly from the level present at discharge. While she still experienced mild tiredness after unusually busy days, this was within normal limits and responded well to rest. The energy conservation techniques taught by the physiotherapist helped her structure her day to avoid fatigue crashes. This is a meaningful outcome because fatigue is one of the most persistent symptoms in iMCD recovery.

Nutrition

Appetite returned to normal levels. She was eating regular meals with adequate protein intake. Hydration targets were consistently met. Her weight remained stable, which was a positive indicator given the unexplained weight loss that was part of her initial presentation. The role of nutrition in supporting immune recovery was evident in her overall progress.

Medical Stability

No recurrent fever occurred during the 12-week period. No new lymph node enlargement was detected. Inflammatory markers remained stable across all monthly reviews. Blood pressure was consistently well controlled. Blood sugar levels remained in the prediabetes range without progression. No infections were documented despite the patient being on immunosuppressive therapy.

Emotional Well-Being

The mild anxiety about disease recurrence that was present at discharge had reduced considerably. Mrs. Naqvi resumed activities she enjoyed, including reading and community interaction. Her sleep pattern had normalized. While some anxiety about the future remained, which is entirely appropriate for someone with a rare condition requiring long-term follow-up, it no longer interfered with her daily functioning.

Family Impact

The husband reported significantly reduced stress. He could return to his normal routine while knowing his wife was being cared for by trained professionals. The daughter in Noida could focus on her work with the confidence that daily monitoring was in place. The caregiver burden was substantially reduced, which is an important outcome that is often overlooked when measuring recovery success.

Remaining Challenges

At 12 weeks, some limitations persisted. Mrs. Naqvi still could not carry heavy groceries, climb multiple flights of stairs without rest, or perform heavy household cleaning. These are reasonable limitations given her age, her knee osteoarthritis, and the severity of the illness she had recovered from. The goal was never to return her to the fitness level of a healthy 30-year-old, but to help her achieve the best possible functional level for her specific situation.

Long-Term Care Needs

Castleman Disease requires indefinite follow-up. Even after 12 weeks of positive progress, Mrs. Naqvi will need regular hematology reviews, ongoing inflammatory marker monitoring, and continued vigilance for relapse. The home care plan was transitioned to a maintenance phase with reduced nursing frequency but continued monthly doctor visits. The family remained educated and alert to warning signs.

Key Clinical Learnings

Learning 1: Rare Diseases Demand Structured Home Monitoring

Castleman Disease is rare enough that most primary care physicians have limited exposure to it. When a patient with iMCD is sent home, the monitoring requirements are specific: inflammatory symptoms, lymph node status, and immune function. Generic home care without disease-specific training would miss critical findings. The home nursing team in this case was briefed on the specific parameters to monitor for iMCD, which is different from what you would monitor for diabetes, heart failure, or post-surgical recovery.

Learning 2: The Post-Discharge Period Is a Clinical Phase, Not a Break

Discharge from the hospital does not mean the patient is recovered. It means the acute phase has been stabilized enough to continue care in a less resource-intensive setting. For iMCD, the post-discharge period involves ongoing immunosuppression, infection risk, nutritional recovery, and rehabilitation. Treating this period as a passive recovery time, rather than an active clinical phase, is a mistake that can lead to preventable complications.

Learning 3: Rehabilitation Must Be Individually Paced

There is no standard physiotherapy protocol for post-iMCD recovery. The physiotherapy in this case was adjusted weekly based on the patient’s energy levels, response to exercise, and clinical status. Pushing too hard could have triggered a setback. Moving too slowly would have delayed functional recovery. The key was continuous assessment and adjustment, which is what individualized home care planning makes possible.

Learning 4: Comorbidity Management Cannot Be Paused

When a rare condition dominates the clinical picture, there is a risk of neglecting pre-existing conditions. Mrs. Naqvi’s hypertension, prediabetes, B12 deficiency, and osteoarthritis did not go away when she was diagnosed with Castleman Disease. In fact, the corticosteroid therapy could have worsened her blood sugar control. The home care plan explicitly included monitoring and management of all comorbidities alongside the iMCD follow-up. Chronic disease management at home must continue even when a new acute condition takes priority.

Learning 5: Family Education Is as Important as Clinical Care

The best home nursing team can only be present for part of the day. The family is present 24 hours a day. If the family does not understand what to watch for, how to respond, and when to seek help, there will be gaps in care. In this case, the combination of a clinical psychologist daughter and structured family education sessions meant the family was well equipped to supplement the professional care. Not every family has this advantage, which is why the education component must be thorough and repeated, not a single discharge briefing.

Learning 6: Infection Prevention in Immunocompromised Patients Is Non-Negotiable

The fact that zero infections occurred over 12 weeks in an immunosuppressed patient living in Ghaziabad, where seasonal respiratory infections are common, is a meaningful outcome. This did not happen by chance. It happened because of daily infection surveillance, hygiene enforcement, visitor management during illness seasons, and early response to any symptom that could indicate an infection. Infection prevention at home requires consistent effort, not occasional attention.

Frequently Asked Questions

Can Castleman Disease patients recover at home?

Yes. Once medically stable and cleared for discharge by the treating hematologist, patients with Castleman Disease can recover at home with appropriate support. Home nursing provides daily clinical monitoring, physiotherapy helps rebuild physical strength, nutritional support addresses the weight loss and appetite changes common in this condition, and regular hematology follow-up ensures disease activity is tracked. The key requirement is that the patient must be clinically stable before transitioning to home care. Home care is not a substitute for hospital treatment during the acute phase.

Is Castleman Disease a form of cancer?

No. Castleman Disease is classified as a rare lymphoproliferative disorder, not as a traditional cancer. It involves abnormal enlargement of lymph nodes and excessive immune system activation. However, it requires specialist hematology treatment, can be serious or life-threatening if untreated, and requires long-term follow-up because it can relapse. Some forms of Castleman Disease are associated with an increased risk of developing lymphoma, which is why ongoing monitoring is important. But the disease itself is not cancer.

Why is infection prevention so important for Castleman Disease patients at home?

The treatments used for Castleman Disease, particularly monoclonal antibody therapy and corticosteroids, work by suppressing parts of the immune system. While this controls the excessive immune activation causing the disease, it also reduces the body’s ability to fight off infections. A common cold that a healthy person might recover from in a few days could become a serious respiratory infection in an immunosuppressed patient. This is why daily temperature checks, hygiene monitoring, and prompt response to any infection signs are essential components of home care for these patients.

Why is physiotherapy recommended after Castleman Disease treatment?

Castleman Disease causes prolonged illness, significant fatigue, muscle wasting from inactivity during hospitalization, and general deconditioning. Physiotherapy addresses all of these issues systematically. It rebuilds muscle strength through progressive resistance exercises, improves endurance through graduated walking programs, restores balance to reduce fall risk, and teaches energy conservation techniques so the patient can resume daily activities without exhausting themselves. Without physiotherapy, recovery from the functional impact of the illness would be much slower and less complete.

What warning signs require immediate medical attention during home recovery?

The following symptoms require urgent medical evaluation: persistent fever that does not resolve within 24 hours, rapidly enlarging lymph nodes in any part of the body, severe fatigue that prevents the patient from getting out of bed, difficulty breathing or new chest discomfort, unexplained bleeding from any site, and sudden significant weight loss over days rather than weeks. These could indicate disease relapse, a serious infection, or another complication that requires hospital-level evaluation. Families should not wait for the next scheduled appointment if these symptoms appear.

Why are home doctor visits beneficial for rare disease follow-up?

Home doctor visits offer several advantages for rare disease patients. The doctor can observe the patient in their actual living environment, which may reveal factors affecting recovery that a clinic visit would not show. The doctor can review the home monitoring data in context, examine the patient when they are most relaxed rather than after traveling to a hospital, and spend more time with the family compared to a busy outpatient department. For a condition like iMCD where early detection of relapse is critical, having a doctor who regularly visits the home and knows the patient’s baseline well can make a meaningful difference in outcomes.

Can patients with Castleman Disease return to normal life?

Many patients can regain a significant degree of normalcy with appropriate treatment, rehabilitation, and long-term follow-up. “Normal life” in this context means resuming independent daily activities, engaging socially, and enjoying hobbies and interests. However, it is important to understand that life after iMCD includes ongoing medical follow-up, continued vigilance for relapse, and some permanent lifestyle adjustments. The pace of recovery varies between individuals. Some patients recover quickly, while others need months of rehabilitation. The key is to have realistic expectations and to measure progress against the patient’s own baseline, not against some ideal standard.

How long does home recovery typically take after hospitalization for Castleman Disease?

There is no standard timeline because recovery depends on the severity of the disease, the duration of illness before diagnosis, the patient’s age and comorbidities, and their individual response to treatment. In this case study, meaningful improvement was observed over 12 weeks of structured home healthcare. However, the recovery process continues beyond that period. Long-term follow-up for iMCD is indefinite because relapse can occur even years after initial successful treatment. The intensive home care phase may last weeks to months, but the monitoring phase continues for life.

What role does nutrition play in Castleman Disease recovery at home?

Nutrition plays a direct role in recovery. The disease itself causes weight loss and poor appetite. The treatments, particularly corticosteroids, can affect blood sugar levels and appetite patterns. Adequate protein intake is needed for muscle recovery after the deconditioning caused by prolonged illness. Proper hydration supports immune function and kidney health. For patients with comorbidities like prediabetes, the nutritional plan must balance the need for adequate caloric intake with blood sugar management. A home nurse can monitor dietary intake daily and identify problems early, before they affect clinical outcomes.

How does home healthcare reduce hospital readmissions for rare disease patients?

Home healthcare reduces readmissions by providing continuous monitoring that catches problems early, before they escalate to the point of requiring hospitalization. A rising temperature is treated promptly before it becomes a full-blown infection. A slight decrease in appetite is investigated before it becomes significant weight loss. A small change in lymph node size is reported to the doctor before it represents extensive disease progression. Additionally, home healthcare ensures medication adherence, which prevents the treatment failures that often lead to hospitalization. The evidence consistently shows that structured post-discharge home care reduces readmission rates across a wide range of conditions.

Dr. Ekta Fageriya, MBBS - Geriatric Medicine Specialist

Dr. Ekta Fageriya, MBBS

RMC Registration No.: 44780

Specialization: Geriatric Medicine

Clinical Experience: 7 Years

This case study has been reviewed and prepared for educational purposes to illustrate the role of structured home healthcare in post-discharge recovery for patients with rare lymphoproliferative disorders.

Supporting Clinical Documents

The following clinical documents informed the development of this case study and the home care plan:

  • Hospital discharge summary with diagnosis, treatment summary, and discharge medications
  • Complete blood investigation reports including inflammatory markers
  • Contrast-enhanced CT scan and PET-CT imaging reports
  • Excisional lymph node biopsy and immunohistochemistry reports
  • Bone marrow examination report
  • Prescription records and medication list at discharge
  • Home care nursing assessment and progress notes
  • Physiotherapy assessment and session notes
  • Monthly doctor home visit records

Note: Specific laboratory values, medication names, and imaging details are not reproduced here to maintain focus on the home care clinical narrative.

Contact AtHomeCare

Corporate Office Unit No. 703, 7th Floor, ILD Trade Centre, D1 Block, Malibu Town, Sector 47, Gurgaon, Haryana 122018
Phone 9910823218

Medical Disclaimer: Every patient is unique. Treatment decisions must always be made by qualified healthcare professionals based on individual clinical evaluation. Emergency symptoms require immediate hospital care. Home healthcare complements, but does not replace, emergency medical services. This case study is entirely fictional and created solely for educational purposes. It does not represent a real patient. Any resemblance to actual individuals is purely coincidental.

Related Reading

Explore more resources on home healthcare, elderly care, and recovery

Leave A Comment

All fields marked with an asterisk (*) are required